ReviewCochrane evidence synthesis and methods2023
What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.
Review in Cochrane evidence synthesis and methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness.Health affairs scholar · 2024Article
- Industry influences on science and policy: identifying levers for independence.Tobacco control · 2024Article
- Quantifying Industry Spending on Promotional Events Using Open Payments Data.JAMA health forum · 2024Article
- Promoting opioids, a story about how to influence medical science and opinions.Frontiers in medicine · 2024Article
- What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.Cochrane evidence synthesis and methods · 2023Review
- Industry influence on mental health research: depression as a case example.Frontiers in medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To identify all scientific papers that used internal industry documents in the pharmaceutical sector and analyze what and how the scientific literature learned about corporate influence in the pharmaceutical sector through these internal documents. Design: Scoping review. Methods: Using different series of keywords, we searched six databases, PubMed, Scopus, Web of Science, CINAHL, Business Source Complete, and PAIS, for peer-reviewed journal articles analyzing pharmaceutical corporations' internal documents. We completed the scoping review using a purposive snowball sampling method to extract relevant case studies and peer-reviewed journal articles from relevant articles' reference lists when our search keywords failed to capture them. To analyze the content of the literature and better categorize the types of corporate strategies at play in the pharmaceutical sector, we used categories of ghost-management previously developed in the literature. Results: We identified 37 peer-reviewed papers in the final results. All the articles included in the final results are published in English. Almost all articles obtained most of their internal document data through legal proceedings. All 37 articles unveil dynamic ghost-management strategies that pharmaceutical corporations employ to safeguard their corporate interest. The strategies identified relate to scientific capture ( Conclusion: The scientific literature using internal documents confirmed widespread corporate influence in the pharmaceutical sector. While the academic literature used internal documents related to only a handful of products, our research results, based on ghost-management categories, demonstrate the extent of corporate influence in every interstice of pharmaceutical markets, particularly in clinical research and clinical practice. It also allows us to better refine the conceptual categories of ghost-management to better map corporate influence and conflict of interest.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.